Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9

GCDH encodes for the enzyme catalyzing the sixth step of the lysine catabolism pathway. Biallelic pathogenic variants in GCDH have been associated with glutaric aciduria type 1 (GA1). In this study CRISPR/Cas9 technology was used to create an isogenic GCDH knock-out human iPSC line. One clone with a...

Full description

Bibliographic Details
Main Authors: Imke M.E. Schuurmans, Ka M. Wu, Clara D.M. van Karnebeek, Nael Nadif Kasri, Alejandro Garanto
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506123000557
_version_ 1827937857606516736
author Imke M.E. Schuurmans
Ka M. Wu
Clara D.M. van Karnebeek
Nael Nadif Kasri
Alejandro Garanto
author_facet Imke M.E. Schuurmans
Ka M. Wu
Clara D.M. van Karnebeek
Nael Nadif Kasri
Alejandro Garanto
author_sort Imke M.E. Schuurmans
collection DOAJ
description GCDH encodes for the enzyme catalyzing the sixth step of the lysine catabolism pathway. Biallelic pathogenic variants in GCDH have been associated with glutaric aciduria type 1 (GA1). In this study CRISPR/Cas9 technology was used to create an isogenic GCDH knock-out human iPSC line. One clone with a biallelic deletion (SCTCi019-A) in GCDH was obtained and fully characterized, revealing a normal karyotype, no off-targets detected and expression of pluripotency markers. This iPSC line can contribute to gain insights in the molecular mechanism of disease.
first_indexed 2024-03-13T08:31:51Z
format Article
id doaj.art-52d9d77ce58e4212930f6f2ce2493905
institution Directory Open Access Journal
issn 1873-5061
language English
last_indexed 2024-03-13T08:31:51Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Stem Cell Research
spelling doaj.art-52d9d77ce58e4212930f6f2ce24939052023-05-31T04:44:05ZengElsevierStem Cell Research1873-50612023-06-0169103069Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9Imke M.E. Schuurmans0Ka M. Wu1Clara D.M. van Karnebeek2Nael Nadif Kasri3Alejandro Garanto4Department of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands; Amalia Children’s Hospital, Radboud University Medical Center, Nijmegen, The Netherlands; Departments of Pediatrics and Human Genetics, Emma Center for Personalized Medicine, Amsterdam University Medical Centers, University of Amsterdam, The NetherlandsDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The NetherlandsDepartments of Pediatrics and Human Genetics, Emma Center for Personalized Medicine, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands; United for Metabolic Diseases, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The NetherlandsDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The NetherlandsDepartment of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands; Amalia Children’s Hospital, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Corresponding author.GCDH encodes for the enzyme catalyzing the sixth step of the lysine catabolism pathway. Biallelic pathogenic variants in GCDH have been associated with glutaric aciduria type 1 (GA1). In this study CRISPR/Cas9 technology was used to create an isogenic GCDH knock-out human iPSC line. One clone with a biallelic deletion (SCTCi019-A) in GCDH was obtained and fully characterized, revealing a normal karyotype, no off-targets detected and expression of pluripotency markers. This iPSC line can contribute to gain insights in the molecular mechanism of disease.http://www.sciencedirect.com/science/article/pii/S1873506123000557
spellingShingle Imke M.E. Schuurmans
Ka M. Wu
Clara D.M. van Karnebeek
Nael Nadif Kasri
Alejandro Garanto
Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9
Stem Cell Research
title Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9
title_full Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9
title_fullStr Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9
title_full_unstemmed Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9
title_short Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9
title_sort generation of an induced pluripotent stem cell line carrying a biallelic deletion sctci019 a in gcdh using crispr cas9
url http://www.sciencedirect.com/science/article/pii/S1873506123000557
work_keys_str_mv AT imkemeschuurmans generationofaninducedpluripotentstemcelllinecarryingabiallelicdeletionsctci019aingcdhusingcrisprcas9
AT kamwu generationofaninducedpluripotentstemcelllinecarryingabiallelicdeletionsctci019aingcdhusingcrisprcas9
AT claradmvankarnebeek generationofaninducedpluripotentstemcelllinecarryingabiallelicdeletionsctci019aingcdhusingcrisprcas9
AT naelnadifkasri generationofaninducedpluripotentstemcelllinecarryingabiallelicdeletionsctci019aingcdhusingcrisprcas9
AT alejandrogaranto generationofaninducedpluripotentstemcelllinecarryingabiallelicdeletionsctci019aingcdhusingcrisprcas9